Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C1GALT1 pseudogene 1 (C1GALT1P1) is a non-functional genetic sequence in the human genome that is homologous to the active C1GALT1 gene. It does not produce a protein product and is not involved in any known cellular processes, molecular functions, or human diseases. C1GALT1P1 serves primarily as an annotated pseudogene rather than an active participant in physiological or pathological mechanisms. Important distinction: The active gene, C1GALT1 (core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1), is a crucial glycosyltransferase enzyme responsible for the formation of the core 1 O-glycan structure on glycoproteins, participating in O-glycosylation and cellular processes such as development, angiogenesis, and cancer progression[1][2][3][4][5]. C1GALT1 is implicated as a potential therapeutic target and studied in cancer, but this does not apply to its pseudogene, C1GALT1P1. If you are seeking information on the therapeutic target or enzyme "C1GALT1," please clarify, as C1GALT1P1 does not serve these biological roles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C1GALT1 pseudogene 1 (C1GALT1P1).